Difficulty: Medium
Average Score: 78%
Practice
Which of the following medications is most likely to be associated with interictal spikes or epileptiform abnormalities on EEG?
Correct answer
A
Rationale
In this question, the correct answer is A) cefepime. Cefepime is a cephalosporin antibiotic that has been known to be associated with interictal spikes or epileptiform abnormalities on EEG, particularly in patients with renal impairment or high doses. This is due to its potential to lower the seizure threshold in susceptible individuals.
Doxycycline (B) is an antibiotic from the tetracycline class and is not typically associated with EEG abnormalities. Fluoxetine (C) is a selective serotonin reuptake inhibitor (SSRI) used for depression and is not known to cause interictal spikes. Methylphenidate (D) is a stimulant commonly used to treat ADHD and does not typically have EEG abnormalities as a side effect.
Understanding the potential side effects and interactions of psychotropic medications is crucial for healthcare providers, especially when managing patients with comorbid conditions. This knowledge can help in making informed decisions regarding medication selection, dosing, and monitoring to ensure the safety and well-being of patients. It also highlights the importance of individualizing treatment based on a patient's unique characteristics and medical history.
Doxycycline (B) is an antibiotic from the tetracycline class and is not typically associated with EEG abnormalities. Fluoxetine (C) is a selective serotonin reuptake inhibitor (SSRI) used for depression and is not known to cause interictal spikes. Methylphenidate (D) is a stimulant commonly used to treat ADHD and does not typically have EEG abnormalities as a side effect.
Understanding the potential side effects and interactions of psychotropic medications is crucial for healthcare providers, especially when managing patients with comorbid conditions. This knowledge can help in making informed decisions regarding medication selection, dosing, and monitoring to ensure the safety and well-being of patients. It also highlights the importance of individualizing treatment based on a patient's unique characteristics and medical history.